Global Age-Related Macular Degeneration Drug Pipeline Capsule -- 2011

September 2011
Biomedical Market Newsletter;9/30/2011, Vol. 21, p32
The article presents the report of Fore Pharma entitled "Global Age-Related Macular Degeneration Drug Pipeline Capsule-2011." The report outlines the primary research and development (R&D) activities of the age-related macular degeneration drug market. It is also upgraded with the full coverage of partnerships and licensing activities.


Related Articles

  • New test helps patients self-monitor for AMD lesions. Charters, Lynda // Ophthalmology Times;7/1/2002, Vol. 27 Issue 13, p26 

    Focuses on the efficiency of the macular computerized psychophysical test (MCPT) for self-detection of age-related macular degeneration (AMD) related lesions. Results of a pilot study conducted on the tests; Administration of the MCPT and Amsler Grid to patients to test the accuracy of MCPT;...

  • The diagnosis of autosomal dominant late-onset retinal degeneration in two sisters. Styles, C J; Dhillon, B; Wright, A F // Eye;May2003, Vol. 17 Issue 4, p530 

    Eye (2003) 17, 530-532. doi:10.1038/sj.eye.6700408

  • AMD clinics failing on treatment waiting times. McCormick, Emily // Optometry Today;10/5/2012, Vol. 52 Issue 19, p7 

    The article reports that only than half of people suffering from age-related macular degeneration (AMD) are receiving treatment within the recommended two-week timeframe.

  • Insight into age-related macular degeneration: New vision in sight. Richter, C // Cell Death & Differentiation;Mar2001, Vol. 8 Issue 3, p207 

    Discusses age-related macular degeneration. Incidence; Major consequences of the release of cytochrome c from mitochondria into the cytosol; Mitochondrial respiratory chain; Level of retinal decreased by retinal dehydrogenase.

  • More than meets the eyes? Jacobs, Tom // Nature Biotechnology;Oct2004, Vol. 22 Issue 10, p1221 

    This article focuses on retinal degeneration. Age-Related Macular Degeneration (AMD) is the prime cause of blindness in those over 50, affecting 13-15 million people in the United States alone. Of the two forms, wet and dry: the former comprises only 10-15% of AMD cases, but progresses faster to...

  • Macular pigment response to a supplement containing meso-zeaxanthin, lutein and zeaxanthin. Bone, Richard A.; Landrum, John T.; Yisi Cao; Howard, Alan N.; Alvarez-Calderon, Francesca // Nutrition & Metabolism;2007, Vol. 4, p12 

    Background: Age-related macular degeneration (AMD) is a disease with multiple risk factors, many of which appear to involve oxidative stress. Macular pigment, with its antioxidant and light-screening properties, is thought to be protective against AMD. A result has been the appearance of dietary...

  • Pegaptanib benefits continue in second year of AMD trial. Charters, Lynda // Ophthalmology Times;12/1/2005, Vol. 30 Issue 23, p32 

    The article presents information on a study conducted on pegaptanib. As per the study it was found that benefits pegaptanib will continue in second year of age-related macular degeneration trial. The study consisted of two randomized, double-masked, sham-controlled, dose-ranging trials. The...

  • Peripheral retinal degenerations. Macalister, Graham; Sullivan, Paul // Optometry Today;9/30/2011, Vol. 51 Issue 19, p44 

    This article examines retinal degenerations and congenital anomalies which the optometrist may encounter in the periphery of an asymptomatic patient. The key identifying features are described and for each condition, the following questions are asked: Is it a risk factor for retinal detachment...

  • Dietary fat and the risk of age-related maculopathy: the POLANUT Study. Delcourt, C; Carrière, I; Cristol, J-P; Lacroux, A; Gerber, M // European Journal of Clinical Nutrition;Nov2007, Vol. 61 Issue 11, p1341 

    This study aimed at assessing the associations of dietary fat with the risk of age-related maculopathy (ARM), in the framework of a population-based study from southern France. Nutritional data were collected using a dietitian-administered food-frequency questionnaire. ARM was classified from...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics